February 23, 21 - 12:19 pm - LABS

Pfizer vaccine against COVID-19 obtains final use approval in Brazil

The Brazilian health regulatory agency, Anvisa, granted this Tuesday the definitive registration to Pfizer‘s vaccine against COVID-19, developed in partnership with the German laboratory BioNTech. According to the director-president of the regulatory agency, Antônio Barra Torres, the analysis for the immunizer’s definitive approval took 17 days.

Read more about it